Scienture Holdings Faces Delisting Concerns

Ticker: SCNX · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1382574

Scienture Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyScienture Holdings, Inc. (SCNX)
Form Type8-K
Filed DateJan 8, 2025
Risk Levelhigh
Pages4
Reading Time5 min
Key Dollar Amounts$0.00001
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

TL;DR

Scienture Holdings might get kicked off Nasdaq. Big trouble.

AI Summary

Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC) filed an 8-K on January 8, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The filing indicates potential issues with meeting Nasdaq's continued listing standards, though specific details regarding the rule or the company's plan to regain compliance are not provided in this excerpt.

Why It Matters

This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the company's stock being removed from Nasdaq, impacting investor liquidity and valuation.

Risk Assessment

Risk Level: high — The notice of delisting or failure to satisfy continued listing rules directly indicates a significant risk to the company's stock exchange status.

Key Players & Entities

  • Scienture Holdings, Inc. (company) — Registrant
  • TRxADE HEALTH, INC (company) — Former company name
  • XCELLINK INTERNATIONAL INC. (company) — Former company name
  • TRXADE GROUP, INC. (company) — Former company name
  • January 3, 2025 (date) — Earliest event reported
  • January 8, 2025 (date) — Filing date

FAQ

What specific continued listing rule has Scienture Holdings, Inc. failed to satisfy?

The provided excerpt does not specify which particular continued listing rule Scienture Holdings, Inc. has failed to satisfy.

What is Scienture Holdings, Inc.'s plan to regain compliance with Nasdaq's listing standards?

The excerpt does not detail Scienture Holdings, Inc.'s plan to regain compliance with the listing standards.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on January 3, 2025.

What was Scienture Holdings, Inc. formerly known as?

Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC, TRXADE GROUP, INC., and XCELLINK INTERNATIONAL INC.

What is the SIC code for Scienture Holdings, Inc.?

The Standard Industrial Classification (SIC) code for Scienture Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 1,224 words · 5 min read · ~4 pages · Grade level 11.2 · Accepted 2025-01-08 16:53:34

Key Financial Figures

  • $0.00001 — ch registered Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Surendra Ajjarapu Surendra Ajjarapu Chief Executive Officer Date: January 8, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.